mdt in omcspc in the oriole and stomp trials
Published 1 year ago • 63 plays • Length 2:48Download video MP4
Download video MP3
Similar videos
-
11:39
psmafore trial & enzalutamide with 177lu-psma-617 for mcrpc | dr. dharmender malik | 05th knowledge
-
8:09
agent for high-grade nmibc meets primary endpoint in phase iii trial
-
2:37
arches trial: enzalutamide plus adt for mhspc
-
4:56
fred saad, esmo 2022: phase iii propel trial of abiraterone olaparib in prostate cancer
-
2:25
phase i trial of arx517, an anti-psma adc, in mcrpc
-
3:09
main duct ipmn
-
13:40
2022 recap: new treatments and approaches in #prostatecancer | #markscholzmd | pcri
-
10:22
what is it like having prostate radiotherapy treatment?
-
1:55
arches trial overview: adt plus enzalutamide for metastatic hormone-sensitive prostate cancer
-
1:08
dr. inman on immunotherapy combinations in bladder cancer
-
40:03
psma & lutetium-177 in 2022 | eugene kwon, md | diy combat manual for beating prostate cancer part 4
-
2:46
dr. sweeney on the phase iii enzamet trial in metastatic hormone-sensitive prostate cancer
-
9:01
implementation of prostate cancer markers in clinical practice
-
0:49
unmet needs for radiotherapy in metastatic and oligometastatic prostate cancer
-
1:37
oncotype testing for breast cancer
-
5:11
enzalutamide adt in men with de novo mhspc: the arches trial
-
13:31
detectors & tracers for lymph node metastases management in prostate cancer: current status & future
-
15:39
multi-omic molecular tumor boards
-
0:49
unmet needs for patients with prostate cancer
-
2:09
dr. oh on the enzamet trial in mhspc
-
7:36
implementing precision medicine in oncology: the impact clinical trials at md anderson
-
18:21
decisional tools to determine need for biopsy and re-biopsy in men with elevated psas